Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers

NCT03564158 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: meropenem-vaborbactam
DRUG: Placebo
DRUG: Moxifloxacin

Sponsor

Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)

Collaborators

[object Object]